Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 474, Issue 1-2, Pages 263-275Publisher
SPRINGER
DOI: 10.1007/s11010-020-03850-3
Keywords
Osteoarthritis; Interleukin 1 beta; Ubiquitin-Specific Peptidase 49; Rat primary chondrocyte; Wnt/beta-catenin signaling pathway
Categories
Funding
- Special Project of Traditional Chinese Medicine Research in Henan Province [2019ZY2080]
Ask authors/readers for more resources
Osteoarthritis (OA) is an age-related chronic joint degenerative disease. Interleukin 1 beta (IL-1 beta) is considered a marker for the progression of OA. In this study, we found that Ubiquitin-Specific Peptidase 49 (USP49) was significantly less expressed in OA patients compared with healthy individuals. Treating primary rat chondrocytes with different concentrations of IL-1 beta resulted in decreased Usp49 expression, while Usp49 overexpression could attenuate IL-1 beta-induced chondrocyte apoptosis by promoting Axin deubiquitination. The deubiquitination of Axin led to the accumulation of the protein, which in turn resulted in beta-catenin degradation and Wnt/beta-catenin signaling cascade inhibition. Interestingly, we also found that [6]-gingerol, an anti-OA drug, could upregulate the protein level of Usp49 and suppress the Wnt/beta-catenin signaling cascade in primary rat chondrocytes. Taken together, our study not only demonstrates that Usp49 can negatively regulate the progression of OA by inhibiting the Wnt/beta-catenin signaling cascade, but also elucidates the underlying molecular mechanisms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available